EGFR and neoplasm: To investigate the tolerated dosage of mAb-Lipo-drugs, the non-tumor bearing BALB/cJ mice were treated with EGFR mAb-Lipo-GC/DM1 at dosages of 0, 6, 12, 18 and 24 mg/kg via i.v. injection.